Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases

Detalles Bibliográficos
Autores principales: Jiang, Tao, Xu, Xiaobo, Chen, Xiaojuan, Ding, Ning, Hu, Qin, Zhou, Caicun, Hu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815344/
https://www.ncbi.nlm.nih.gov/pubmed/33489813
http://dx.doi.org/10.21037/tlcr-20-984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815344/
https://www.ncbi.nlm.nih.gov/pubmed/33489813
http://dx.doi.org/10.21037/tlcr-20-984

Ejemplares similares